ClinicalTrials.gov record
Recruiting Phase 3 Interventional

A Study of JNT-517 in Participants With Phenylketonuria (PKU)

ClinicalTrials.gov ID: NCT06971731

Public ClinicalTrials.gov record NCT06971731. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 5, 2026, 7:08 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Double-Blind, Randomized, Two-Period, Multicenter, Placebo-Controlled, Efficacy and Safety Study of JNT-517 for the Treatment of Participants With Phenylketonuria

Study identification

NCT ID
NCT06971731
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Industry
Enrollment
120 participants

Conditions and interventions

Interventions

  • JNT-517 Tablet Drug
  • Placebo Tablet: BID Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 19, 2025
Primary completion
Feb 29, 2028
Completion
Mar 31, 2028
Last update posted
May 3, 2026

2025 – 2028

United States locations

U.S. sites
10
U.S. states
8
U.S. cities
10
Facility City State ZIP Site status
University of California Los Angeles (UCLA) School of Medicine Los Angeles California 90024 Recruiting
University of Florida (UF) Health Shands Hospital Gainesville Florida 32608 Recruiting
University of South Florida Tampa Florida 33606 Recruiting
Ann & Robert H. Lurie Children's Hospital of Chicago Chicago Illinois 60611 Recruiting
Oregon Health and Science University Portland Oregon 97239 Recruiting
University of Pittsburgh Medical Center (UPMC) - Children's Hospital of Pittsburgh Pittsburgh Pennsylvania 15201 Recruiting
Vanderbilt University Medical Center Nashville Tennessee 37232 Recruiting
University of Texas Southwestern Dallas Texas 75390 Recruiting
University of Texas Health (UTHealth) Science Center at Houston Houston Texas 77030-1501 Recruiting
Utah Health - The University of Utah Hospital Salt Lake City Utah 84112 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 15 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06971731, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 3, 2026 · Synced May 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06971731 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →